Top Markets
#1 PulseChain PulseChain +43.68%
#2 Fake World Assets Fake World Assets +9.04%
#3 Casper Network Casper Network +7.65%
#4 Meteora Meteora +7.09%
#5 Not in Employment, Education, or Training Not in Employment, Education, or Training +6.79%
#6 eCash eCash +5.95%
#7 Magma Finance Magma Finance +5.40%
#8 Bitway Bitway +5.28%
#9 Creditcoin Creditcoin +4.84%
#10 Bitcoin SV Bitcoin SV +4.83%
Coin of the day
PulseChain PulseChain
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Resverlogix Corp. Resverlogix Corp.

Resverlogix Corp.

RVX
Classifica tra le azioni #28673
Resverlogix Corporation is a biotechnology firm currently in advanced clinical... Resverlogix Corporation is a biotechnology firm currently in advanced clinical development, concentrating on developing treatments for illnesses where existing medical solutions are inadequate. The company's leading therapeutic compound is apabetalone (RVX-208), a selective small molecule designed to inhibit bromodomain and extra-terminal proteins. This compound is presently undergoing pivotal Phase III clinical trials for patients afflicted with conditions such as cardiovascular disease, diabetes, various stages of kidney disease (including end-stage renal disease), and neurodegenerative disorders. Furthermore, Resverlogix Corp. has forged an alliance with Eversana Life Science Services, LLC to support the forthcoming commercial rollout of apabetalone as a treatment for COVID-19 across the United States and Canada. The company's main office is located in Calgary, Canada.
Prezzo delle azioni
$0.07339369
Ultima sincronizzazione: 2026-08-18
Capitalizzazione di mercato
$25.24M
Variazione (1 giorno)
5.26%
Variazione (1 anno)
-7.44%
Paese
CA
Scambia Resverlogix Corp. (RVX)

Categoria

Healthcare
Storico del prezzo dell'azione per Resverlogix Corp. (RVX)
Prezzo di chiusura più alto: $0.07 il 2026-08-01

Prezzo di chiusura più basso: $1.62 il 2004-05-01
Storico del prezzo dell'azione di Resverlogix Corp. dal 2004 al 2026
Andamento annuale del prezzo dell'azione
Anno Performance
2026 (TTM) -6.84%
2025 102.06%
2024 -21.85%
2023 -56.62%
2022 -70.32%
2021 -46.30%
2020 -22.98%
2019 -58.94%
2018 55.79%
2017 15.32%
2016 3.07%
2015 197.15%
2014 -11.34%
2013 -71.83%
2012 26.66%
2011 -46.99%
2010 4.14%
2009 49.40%
2008 -88.69%
2007 34.88%
2006 78.65%
2005 76.80%
2004 0.00%
Prezzo dell'azione per aziende simili o concorrenti
Azienda Prezzo dell'azione Variazione 1a% Il paese
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $552.07 39.99%
US
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $168.77 527.63%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.03K 56.22%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $121.05 -14.77%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $753.28 5.84%
CH